If you would like to put a question forward to Tuesday evening's webinar guest speakers, Trident Royalties' CEO, Adam Davidson, Kavango Resources' CEO, Ben Turney, Christopher Nicholson, Managing Director of ACF Equity Research, please do so here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It's a carefully considered note. They factor in £800K licence revenue PA for Heart Valve from FY25. I agree that using the 2026 estimated profit you can come up with a potential share valuation much higher than the 25p they quote for now.
Need to put that into context, the Cavendish 25p target is WITHOUT taking account of heart valve or vascular prospects. It is based on the growth prospects of the contract manufacturing division and Biomaterials licensing stream only.
Seeing as many of us have been invested for the HV and Vascular prospects, that leaves a whole lot more to aim for.
I expect Cavendish will start valuing those latter prospects when further details emerge of possible licensing deals as set out in the strategy update.
Cavendish published a note this morning. Target 25p. That's more realistic.
I expect the target price to come down to 200p or something, but lets be honest, you'll all be chuffed with that anyway, so who cares?
Would you really trust a company that puts out an RNS suggesting that funding was not necessary then two weeks later devalue the company by two thirds.
This is only going one way , and I just feel sorry for those folk that got suckered in above 50p.
Cheers DrM, have a good weekend and I'll now take a peak at our mutual friends efforts at the said company, I'm sure he will have been busy today.
Director buys etc
NotHopeful, fair enough...However, if you want to see Gordon at work take a look at todays highest riser... TYM....
Report link here: https://www.equitydevelopment.co.uk/research/fundraising-looks-well-supported
RUA have announced, subject to shareholder approval at a General Meeting, the intention to raise equity via the combination of an institutional placing of shares, a subscription by certain directors and a retail offer. While the minimum gross proceeds are expected to be at least £4.1m, the full amount raised will be fluid until after the retail offer and shareholder approval. The final proceeds raised should be known after the outcome of the Retail Offer is announced on 8 December, and shareholder vote then comes at the General Meeting on 18 December when we will update our financials and model.
As well as having revenue-generating divisions, RUA’s Structural Heart and Vascular divisions have products in late-stage development and its recent strategy update noted that these will be developed with partners. While partnering greatly reduces RUA’s cash burn in FY 2024 and beyond, the fundraising also eliminates a potential weakness in the size of the upfront payments, royalties and milestones for those deals. This is because before a successful fundraising, potential partners could attempt to offer less, and defer more. After a successful fundraising, RUA should be able to demand better terms from its potential partners.
For now, our valuation is unchanged at £120.3m or 542p per share, but we will update our financials and valuation after the completion of the fundraising and RUA’s interim results on the same day.
Bought this many years ago at around 40 something p, then sold it at around 60 something p. Saw it shooting up to over a pound years later. I was gutted for selling it too soon. Now, it is back to under 12p! Wow, how dramatic!
So, I am in for a small punt at 11.7p, hoping for a good rebound. Good luck everyone and have a great day.
Totally agree with Flava, no need to worry about the price fluctuations unless your trading over the short term. If you are trading over the short term then I'll assume those that are have some common sense and realise that shares can go up and down in value over the VERY short term. I think we'll just agree to disagree with how we perceive the views of short term traders and the relevance on their messages on this board.
I don't normally agree with MAJWandCo. on everything, but he has been quite right recently with his calls, and I do have to give him credit for that. Sometimes we agree to disagree, but that's life, and everyone has their own opinion. I wouldn't worry too much about price fluctuations unless you're not holding for the long term. GLA.
Nothopeful,
I could not agree less with your theory of 'Sell at a price higher than you bought at, isn't that why we all invest'
He fabricates fictional events and targets that he never has any intention of holding to, he simply wants enough 'greater fools' to buy in, which acts as his exit liquidity for his 20% profit.
I post the question to you, regarding your theory. If Gordon Bennett was buying cars from a scrap yard for £150, rolling the mileage back by 100,000 miles, then promoting them on a public forecourt as stunning, well looked after vehicles, with a sale price of £1500, would that also just be a simple case of 'buy low and sell high'?
Of course it wouldn't, that would be lying, cheating, immoral, pond life behaviour.
In your theory, 'well we should just all join in and sell clocked cars also'. No thanks.
Check out the share prices 30 days after GB and his crew have finished their ramp, and often you will see a HUGE retracement, which makes my extreme car sales example actually look quite befitting.
DrMicho, I understand the bit about "Others naivety", but surely if these "Others" who are so called "locked in" just goes to show that they are buying for the short term, if they were in it for the long term they wouldn't be "Locked In".
Just in from HL,
'RUA Life Sciences plc Retail Offer
Important information about your shares
What is happening?
RUA Life Sciences plc have announced their intention to raise up to £4.85m via a Placing for institutional investors and a Retail Offer for individual investors.
RUA Life Sciences plc have decided not to issue a prospectus as part of the fundraising. This means that the Offer has been limited to the sterling equivalent of €8 million and may only be open for a very short period. It also means that information relating to the fundraising is limited to the Company announcement.
Applications are due to close at 3:30pm on Thursday 07 December. Due to the nature of the fundraising, applications can close at any time and without prior warning.
Shares are being offered at a fixed price of 11 pence.
The minimum application for the Retail Offer is £100.
By applying for shares in the Offer you are deemed to have read, understood and agreed to the HL Retail Offer Terms and Conditions, HL Retail Offer Risk Warning and the Company Announcement. These documents can be found in the Secure Messaging Centre of your online account.
Hargreaves Lansdown will receive 0.6% commission on the total allocation from the issuer as part of the Offer.'
NotHopeful, Im with Maj on this one. Gordon jumps on every daily riser and predicts crazy SP prices and more often than not gets others locked in and moves on swiftly. He is now over on FAB ramping away as he has locked himself in there which he thoroughly deserves. Gordon is another chancer that jumps on others naivety....
Hi Maj, Not being funny, but perhaps you could do well by following Gordon a bit more.......... Sounds like Gordon has a good idea....... Sell at a price higher than you bought at, isn't that why we all invest. You don't have to follow his "Pumps" if you're worried about his methods of investing. Just saying.
Gordon Bennett,
https://www.lse.co.uk/profiles/gordonbennett1/
Posts in last 30 days: RUA 24
Of course everyone knows you're not in RUA now, you're only ever in for the pump, always long gone when the dump arrives.
Pond life
At this point, flava is topping up with so many shares that they'll have to make a bid for the company.
Anyway, here we are folks.
Top up time it is.
Strong buy at these levels for a likely good recovery on third-party backer news.
Wait for the broker coverage too!
RESULTS WONT LOOK PRETTY
IF I CAN BUY FOR 11.5 I WILL AGAIN
Yep, all rosy here. 80% down from the short-lived recent peak of what - just over a week ago?
This is a no brainer now results due out next week
Company back on track :)
Am losing count of the 50,000 buys, someone building a stake here.
DYOR
This raise now sets up the company on a solid footing, very good buy down here IMO and I am averaging down.
DYOR...Expecting 20p plus next few sessions IMO.